A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: The ADMIRE (AMP579 Delivery for Myocardial Infarction REduction) study

Stephen L. Kopecky, Ronnier J. Aviles, Malcolm R. Bell, Joseph K. Lobl, Diane Tipping, Gregg Frommell, Karen Ramsey, Anne E. Holland, Mark Midei, Abnash Jain, Mirle Kellett, Raymond J. Gibbons

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Fingerprint Dive into the research topics of 'A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: The ADMIRE (AMP579 Delivery for Myocardial Infarction REduction) study'. Together they form a unique fingerprint.

Medicine & Life Sciences